Twenty-Four-Month Clinical Comparison of Two Bulk-Fill and Microhybrid Composite Restorations (Clinical)

March 10, 2020 updated by: Emine Sirin Karaarslan, Tokat Gaziosmanpasa University

ABSTRACT Objective The aim of this study was to evaluate the clinical performance of one microhybrid and two bulk-fill resin composites in Class II cavities for up to two years.

Materials and methods In total, 75 Class II restorations were made in 25 patients, using three restorative materials: two nanohybrid bulk-fill resin composites, Sonic Fill (SF) and x-tra fil (XF), and a microhybrid composite, Filtek Z-250 (FZ). The restorations were blindly evaluated by two examiners at baseline and at 6, 12, and 24 months, using U.S. Public Health Service (USPHS) criteria. The restoration groups for each category were compared using the Pearson chi-square test, and the Cochran Q-test was used to compare the changes across different time points within each restorative material (p <0.05).

Study Overview

Study Type

Interventional

Enrollment (Actual)

25

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 22 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patient in need of restoration of caries lesion (diagnosed with bitewing radiograph and clinical examination);
  • teeth in need of restoration to be first or second molars or permanent premolars;
  • at least three Class II restorations required in each patient and the number of restorations of each material to be equal in each patient;
  • the antagonist and adjacent tooth in contact;
  • pulp vitalized and free of painful symptoms; teeth involved not to have undergone direct pulp capping;
  • no history of hypersensitivity in the teeth to be restored;
  • permanent dentition;
  • good oral health and absence of periodontal disease;
  • patients not to have suffered from systemic diseases or allergies;
  • absence of deleterious habits, xerostomia, and bruxism.

Exclusion Criteria:

  • Fewer than 20 teeth;
  • history of existing tooth sensitivity;
  • known allergy to resin-based materials or any of the other materials used in this study;
  • pregnancy or breastfeeding;
  • chronic use of anti-inflammatory drugs, analgesic, and/or psychotropic drugs;
  • non-vital teeth;
  • abutment teeth for fixed or removable prostheses.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Bulk-fill resin composite-sonic activated
5 mm bulk-filling without capping lightcured 40s
Clinical Comparison of Composite Restorations (Two Bulk-Fill and one Microhybrid Composite Resin) to the USPHS Criterias
Other Names:
  • Twenty-Four-Month Clinical Comparison of Two Bulk-Fill and Microhybrid Composite Restorations
Experimental: Bulk-fill resin composite
4 mm bulk-filling without capping lightcured 10s
Clinical Comparison of Composite Restorations (Two Bulk-Fill and one Microhybrid Composite Resin) to the USPHS Criterias
Other Names:
  • Twenty-Four-Month Clinical Comparison of Two Bulk-Fill and Microhybrid Composite Restorations
Experimental: Microhybrid resin composite
2 mm layers, lightcured 20s
Clinical Comparison of Composite Restorations (Two Bulk-Fill and one Microhybrid Composite Resin) to the USPHS Criterias
Other Names:
  • Twenty-Four-Month Clinical Comparison of Two Bulk-Fill and Microhybrid Composite Restorations

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinical Acceptability
Time Frame: Twenty-Four-Month
One week after restoration placement (baseline), patients were recalled and restorations were examined clinically. Direct clinical evaluation of restorations was performed using the USPHS criteria by two independent investigators using mirrors, probes, and bitewing radiographs and scored as Alpha, Bravo, or Charlie. Alpha corresponded to excellent, Bravo to clinically acceptable, and Charlie to clinically unacceptable results. Patients were recalled at 6, 12, and 24 months for assessments of the restorations, using the same criteria as at baseline. At each recall, the same two calibrated evaluators, who were blinded to the restoratives used for cavities and patients, examined the restorations. To ensure a double-blind study, the evaluators were not informed about which filling material had been used on which teeth.
Twenty-Four-Month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 3, 2016

Primary Completion (Actual)

January 3, 2017

Study Completion (Actual)

January 4, 2019

Study Registration Dates

First Submitted

March 3, 2020

First Submitted That Met QC Criteria

March 10, 2020

First Posted (Actual)

March 13, 2020

Study Record Updates

Last Update Posted (Actual)

March 13, 2020

Last Update Submitted That Met QC Criteria

March 10, 2020

Last Verified

March 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 2015/36

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Sharing Time Frame

one year

IPD Sharing Supporting Information Type

  • Study Protocol

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dental Restoration Failure of Marginal Integrity

Clinical Trials on Bulk-Fill and Microhybrid Composite Resins

Subscribe